200 related articles for article (PubMed ID: 24600147)
1. Severe cutaneous adverse drug reactions.
Verma R; Vasudevan B; Pragasam V
Med J Armed Forces India; 2013 Oct; 69(4):375-83. PubMed ID: 24600147
[TBL] [Abstract][Full Text] [Related]
2. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
3. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
[TBL] [Abstract][Full Text] [Related]
4. An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions.
Gelincik A; Cavkaytar O; Kuyucu S
Curr Pharm Des; 2019; 25(36):3881-3901. PubMed ID: 31692425
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous side effects of antiosteoporosis treatments.
Musette P; Kaufman JM; Rizzoli R; Cacoub P; Brandi ML; Reginster JY
Ther Adv Musculoskelet Dis; 2011 Feb; 3(1):31-41. PubMed ID: 22870464
[TBL] [Abstract][Full Text] [Related]
6. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
8. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
9. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.
Paulmann M; Mockenhaupt M
Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083
[TBL] [Abstract][Full Text] [Related]
10. [Adverse cutaneous reactions to drugs].
Suástegui-Rodríguez I; Campos-Jiménez KI; Domínguez-Cherit J; Méndez-Flores S
Rev Med Inst Mex Seguro Soc; 2018; 56(1):64-70. PubMed ID: 29368897
[TBL] [Abstract][Full Text] [Related]
11. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
[TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
13. DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report.
Artuković M; Kustelega J; Lugović-Mihić L
Acta Clin Croat; 2010 Dec; 49(4):479-84. PubMed ID: 21830461
[TBL] [Abstract][Full Text] [Related]
14. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
15. [Drug reaction with eosinophilia and systemic symptoms].
Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
[TBL] [Abstract][Full Text] [Related]
16. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
17. [Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)].
Lobo I; Ferreira M; Velho G; Sanches M; Selores M
Acta Med Port; 2008; 21(4):367-72. PubMed ID: 19094812
[TBL] [Abstract][Full Text] [Related]
18. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
[TBL] [Abstract][Full Text] [Related]
19. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced skin, nail and hair disorders.
Valeyrie-Allanore L; Sassolas B; Roujeau JC
Drug Saf; 2007; 30(11):1011-30. PubMed ID: 17973540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]